Skip to main content

IMPACT Program

Integrating Medicine & Policy to Achieve Health care Transformation

Late Translational, health services and outcomes research is essential for improving patient care, enhancing population health, and shaping effective health care policy through rigorous evaluation and implementation of evidence-based strategies.

Our Mission: IMPACT builds a vibrant, productive community of clinician-scientists and PhD investigators at the Spencer Fox Eccles School of Medicine (SFESOM), dedicated to late translational (T3/T4), health services, and outcomes research. We foster a collaborative, supportive culture that emphasizes career development, mentorship, mutual support, and excellence to maximize our collective impact. 

Our Vision: Transform health care and improve patient and population health outcomes by advancing innovative late translational (T3/T4), health services, and outcomes research that directly enhances patient care and shapes healthcare policy.

Facilitate Recruitment

Partner with departments on co-recruitment, provide competitive funding packages, and support siloed HSR faculty

Build Community

Foster a community of multidisciplinary health services researcher and promote a culture of collaboration, mentorship, and support

Enhance Research and Innovation

Facilitate access to key resources and support for large-scale collaborative research opportunities

Career Development and Mentoring

Provide structured mentorship and training to faculty including grant writing, leadership, and communication

THE LATEST FROM IMPACT

Implementation Science Methods Workshop

Effectiveness-Implementation Hybrid Studies | October 15 and 16

Join us for a 2-day implementation science workshop featuring visiting faculty member Geoffrey Curran, PhD, MA, from the University of Arkansas for Medical Sciences. Dr. Curran is a nationally recognized leader in implementation science and the lead author of seminal articles on effectiveness-implementation hybrid studies and hybrid trials. Co-sponsored by the Dissemination and Implementation Science Core (DISC) of the Utah Clinical and Translational Research Institute (CTSI) and the IMPACT Program (Integrating Medicine & Policy to Achieve Health Care Transformation).

RSVP for Day 1 and Day 2.

Learn more about the event here.

IMPACT Researcher Highlight: Dr. Valerie Vaughn

University of Utah Health has been awarded $30 million from the Patient-Centered Outcomes Research Institute (PCORI) to lead a large clinical study focused on identifying the most effective treatment for AWS. The study will compare phenobarbital, a newer treatment approach, with benzodiazepines, the established standard of care. Valerie Vaughn, MD, MS, Associate Director of IMPACT, will lead the study.

Read the full press release here.
Andrew Wong wearing a blue suit, blue tie, and brown belt.

Welcoming Dr. Andrew Wong

We are excited to announce that Dr. Andrew Wong will be joining the University of Utah as an Assistant Professor in the Division of General Internal Medicine, Department of Internal Medicine, and as IMPACT's Director of Clinical AI Research. Dr. Wong brings a wealth of experience in digital health innovations, AI research, and implementation science and we could not be more enthusiastic to welcome him into the IMPACT & U of U Health research community.